The Laboratory of Experimental Mycology of the Institute of Microbiology, Russian Academy of Sciences, uses mushrooms as raw materials to develop a new type of drug that can enhance immunity and resist viruses. Mushrooms are fungi, some can be eaten, some can't be eaten. According to mycology, mushrooms have a positive effect on the human immune system, which can reduce cholesterol levels in the body, and can even fight cancers against viruses. Bioactive substances extracted from mushrooms are widely used in medicine. In recent years, there has been a new medical direction --- pharmaceutical mycology. The new drug developed by Russian experts using mushrooms as a raw material is a capsule containing 2% lycopene and mushroom bioactive substances. Lycopene, also called carotenoids, is found in tomatoes. People have long found that people who regularly eat tomatoes have a very low risk of developing cancer. Lycopene is usually extracted from tomatoes, but lycopene crystals are expensive because of the complexity of the extraction process. To this end, Russian experts proposed the extraction of lycopene from mushrooms and developed a method for obtaining lycopene from the mushroom mycelium. Little loss of lycopene was extracted using this method, while maintaining the biological activity of the mushroom. Research by researchers using new drugs on animals has shown that this new drug has anti-mutation, anti-radiation, and immune-boosting effects. At the same time, animal experiments have found that new drugs can inhibit the production of 50%-70% of various adenocarcinomas.